Which type of cholesterol does Ezetimibe specifically target?

Ezetimibe specifically targets LDL cholesterol, which is often referred to as "bad" cholesterol because high levels can lead to a buildup of fatty deposits in arteries, increasing the risk of heart disease and stroke. Ezetimibe works by inhibiting the absorption of cholesterol in the intestine, thereby reducing the amount of cholesterol that enters the bloodstream. This results in a decrease in LDL cholesterol levels, making it an effective agent for managing dyslipidemia and improving cardiovascular health.

While other types of cholesterol are significant for understanding lipid profiles, Ezetimibe’s primary mechanism is aimed directly at lowering LDL cholesterol levels. This reduction in LDL is crucial for patients at risk of cardiovascular events, as it helps to decrease the overall cholesterol burden in the body.